Package 51662-1544-1

{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "10352ea7-15c5-5c6c-e063-6394a90ae130", "openfda": {"upc": ["0355150327010"], "unii": ["F850569PQR"], "rxcui": ["1659929"], "spl_set_id": ["c90e2d85-ed94-2c00-e053-2a95a90ad2a0"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL, SINGLE-DOSE (51662-1544-1)", "package_ndc": "51662-1544-1", "marketing_start_date": "20210808"}, {"sample": false, "description": "10 POUCH in 1 CASE (51662-1544-3)  / 1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1544-2)  / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "51662-1544-3", "marketing_start_date": "20220422"}], "brand_name": "NALOXONE HYDROCHLORIDE", "product_id": "51662-1544_10352ea7-15c5-5c6c-e063-6394a90ae130", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1544", "generic_name": "NALOXONE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HYDROCHLORIDE", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA212455", "marketing_category": "ANDA", "marketing_start_date": "20210808", "listing_expiration_date": "20261231"}